Authors: SCOTT R LINTOTT C ZIMMET P CAMPBELL L BOWEN K WELBORN T

Citation: R. Scott et al., ACARBOSE IMPROVES THE METABOLIC ENVIRONMENT OF NIDDM PATIENTS WITH THE PLURIMETABOLIC SYNDROME, Diabetologia, 40, 1997, pp. 1257-1257

Authors: SCOTT R LINTOTT C

Citation: R. Scott et C. Lintott, ACARBOSE IMPROVES THE METABOLIC ENVIRONMENT OF NIDDM PATIENTS WITH THE PLURIMETABOLIC SYNDROME, Diabetes, 46, 1997, pp. 1125-1125

Authors: OSE L SCOTT R BRUSCO O UGARTE AC DESCAMPS O HELLER F PAQUOT N SCHEEN A BERTOLAMI MC FORTI N RICHTER W SELMAIER A ZIEGLASCH HJ KLOER H BADE R WANNER C KOESTER W KRAEMERGUTH A BILIANOU H LEFKOS N EFTHIMIADIS A KASTELEIN J VANDAM M VANDEWIEL A LINTOTT C SUNDT E ISTAD H LOENNECHEN CW UTNE E HOLE T SKARE S URHEIM S CAMPODINCO S MORALES R IZA A ALVAREZ L SY R YEBES R LEE CY TAN A QUEK S VERMAK WJH VORSTER HH RAAL FJ KELLER U NOSEDA G BONETTI T CRAWFORD GM BLOOMFIELD P SUTHERLAND K RYLANCE PB BROOM J BAKSI AK LANT AF HUGHES EA

Citation: L. Ose et al., DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Clinical drug investigation, 10(3), 1995, pp. 127-138